Companies/NexgenRx Inc.

Company profile

NexgenRx Inc.

OTC: NEGXF · Healthcare · Medical - Healthcare Plans

Canadian filerHQ Toronto, ONReports USD

#601 of 1,394 Healthcare companies by revenue47th-percentile growth

EA Score

71B

FH 78DQ —GM 63SS 44

v0.1 · 45/100 weight · provisional

↑ return on equity, Piotroski F · ↓ workforce scale, balance-sheet leverage

Methodology →

Revenue TTM

$13.3M

Rev growth YoY (TTM)

+1.1%

Net income (FY)

$921.9k

Employees

Market cap

$23.1M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$12.5M17.5M CAD2025

Net income$921.9k1.3M CAD2025

Operating income$1.3M1.8M CAD2025

Total assets$26.7M36.6M CAD2025

Liabilities$21.1M29.0M CAD2025

Equity$5.6M7.6M CAD2025

Revenue trend

FY2018 – FY2025 · USD

$5.4M

FY18

$7.2M

FY19

$7.8M

FY20

$9.5M

FY21

$9.6M

FY22

$10.3M

FY23

$12.0M

FY24

$12.5M

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

NexgenRx Inc. booked $12.5M in FY2025 revenue, growing 3.9% year over year — about the middle of the pack among Healthcare companies we track, at a 7.4% net margin.

Peers · Healthcare

Elixxer Ltd.14D NanoViricides, Inc.34D Resverlogix Corp.——Rubicon Organics Inc.63C

Key facts

CEORonald C. Loucks

SectorHealthcare

IndustryMedical - Healthcare Plans

HeadquartersToronto, ON

ExchangeOTC: NEGXF

Employees20

IPO date2017-12-18

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.